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Magnetic resonance imaging (MRI) in cervical carcinoma – 
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MR imaging plays a key role in the diagnosis of cervical carcinoma, especially in the determination of tumour volume.
The a i m  of the present study included: 1) evaluation of correlation of tumour volume as obtained in MRI and during post-
-surgical histological examination; 2) evaluation of correlation between the volume and the greatest dimension of the tumo-
ur (as assessed in MRI) with the following parameters: a) tumour stage according to FIGO classification, b) parametrium in-
filtration, c) presence of lymph node metastases.
M a t e r i a l  a n d  m e t h o d.  Pelvic MRI results (Elscint T2 unit) of 21 patients with cervical carcinoma. Patient age: 37-73
years. Fifteen patients underwent hysterectomy after MRI, in the remaining cases diagnosis was based on biopsy. In 10 patients
treated surgically we compared the MRI-assessed tumour volume with histopathological data. In 16 patients we assessed the
correlation between tumour volume, FIGO tumour stage, parametrium infiltration and lymph node enlargement.
Re s u l t s  a n d  c o n c l u s i o n s.  1) evident correlation was found between MRI and histological examination in the measu-
rements of tumour volume (p=0.764); 2) in patients with cervical carcinoma the sensitivity and specificity of MRI with tumo-
ur volume determination was 100% in differentiation of stage I from the remaining stages; 3) tumour volume correlated best
with stage I and II FIG0 when compared with the determination of the greatest dimension of the lesion; 4) correlations betwe-
en tumour volume and parametrial infiltration were found; 5) no correlation was found between tumour volume and meta-
stases to lymph nodes.
Badanie metodà rezonansu magnetycznego 
raka szyjki macicy – ocena wartoÊci diagnostycznej obj´toÊci guza
Badanie metodà rezonansu magnetycznego (MR) odgrywa kluczowà rol´ w diagnostyce raka szyjki macicy. Jednà z wa˝nych
cz´Êci badania MR jest pomiar obj´toÊci guza.
C e l.  1) ocena zgodnoÊci pomiaru obj´toÊci w badaniu MR z pooperacyjnym badaniem histopatologicznym; 2) ocena kore-
lacji obj´toÊci i najwi´kszego wymiaru raka szyjki macicy (ocenianych w badaniu MR) z nast´pujàcymi parametrami: a) stop-
niem zaawansowania wed∏ug klasyfikacji FIGO; b) naciekaniem przymacicza; c) przerzutami do w´z∏ów ch∏onnych.
M a t e r i a ∏  i m e t o d a.  Materia∏ stanowià badania MR miednicy, wykonane aparatem firmy Elscint 2T, u 21 chorych na ra-
ka szyjki macicy. Wiek chorych od 37 do 73 lat. U 15 pacjentek po badaniu MR przeprowadzono operacj´ usuni´cia macicy,
w pozosta∏ych przypadkach rozpoznanie postawiono na podstawie biopsji. U 10 chorych operowanych dokonano oceny
porównawczej obj´toÊci guza, ocenianej w badaniach MR i histopatologicznym. U 16 chorych analizowano korelacj´ obj´to-
Êci guza ze stopniem zaawansowania, naciekaniem przymacicza i powi´kszeniem w´z∏ów ch∏onnych.
W n i o s k i.  1) stwierdzono wysokà zgodnoÊç badania MR i histopatologicznego (po operacji) w pomiarze obj´toÊci guza,
p=0.764; 2) badanie MR z pomiarem obj´toÊci guza u chorych z rakiem szyjki macicy odznacza si´ 100% czu∏oÊcià i specy-
ficznoÊcià w rozgraniczeniu stopnia I od pozosta∏ych; 3) ocena obj´toÊci guza lepiej koreluje ze stopniem zaawansowania I i II
wg FIGO ni˝ ocena najwi´kszego wymiaru zmiany; 4) stwierdzono korelacj´ pomi´dzy obj´toÊcià guza i naciekaniem przyma-
cicza; 4) nie stwierdzono korelacji obj´toÊci guza z przerzutami do w´z∏ów ch∏onnych.
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In the diagnosis of cervical carcinoma magnetic resonan-
ce imaging (MRI) plays a key role, correlating well with
the results of histological examinations in the assessment
of parimetrial infiltration (94%), and slightly lower in the
evaluation of metastases to lymph nodes (86%). MRI
correlation for establishing tumour stage is 76.5% [1].
A important element of MRI is the measurement
of tumour volume.
In the present study we present the preliminary re-
sults of the analysis of correlations between tumour stage
in FIGO classification, parametrium infiltration and pre-
sence of lymph node involvement.
The aim of the study was to evaluate:
1. Correlation of tumour volume measurements in MRI
and in histological examination after the operation.
2. Correlation between the volume and greatest dimen-
sion of cervical carcinoma assessed with the following
parameters:
a) tumour stage (FIGO classification),
b) parametrial infiltration,
c) metastases to lymph nodes.
Material and method
The material comprised pelvic MRI carried out with El-
scint 2T unit in 21 patients with cervical carcinoma aged
between 37 and 73 years. Fifteen patients underwent hy-
sterectomy after MRI, in the remaining cases the dia-
gnosis was based on biopsy.
The protocol of pelvic MRI:
SET1 sequences in axial projection with large field of vi-
sion:
– study parameters: TR=950ms, TE=18ms, FOV
34x42cm, matrix 252x306, layers 5mm, gap 20%;
FSE sequences with fat saturation, axial projection with
large field of vision:
– study parameters: TR=7200ms, TE=126ms, FOV
37x42cm, matrix 252x306, 5mm layers, gap 20%;
SET1 sequences in sagittal projection, FSE T2 in axial,
sagittal and frontal projections with small field of vision:
– study parameters SE sequences: TR=500ms,
TE=18ms; FSE sequences: TR=7300ms, TE=126ms,
FOV 21x21cm, matrix 252x296, 4mm layers, gap 20%;
SE T1 sequences in axial frontal and sagittal projec-
tions after Gd-DTPA i.v. administration (0.1-0.2 mmol/kg
body weight) with small field of vision, parameters as
above.
In SE T1 sequences with large field of vision the pe-
lvis was examined with reference to lymph nodes and
small pelvis organs. The limit value in the evaluation of
lymph nodes involvement was over 15 mm longitudinal di-
mension.
In the remaining sequences the genital organs were
assessed in detail with particular reference to cervical le-
sions, changes in uterine corpus, vagina, parametrium.
The tumour was measured in the cervix in sagittal, frontal
and transverse planes. Then 3D MRI reconstruction was
carried out and the tumour was outlined in each layer.
Using a special computer programme the outlined areas
were added and tumour volume was calculated. In histo-
logical examinations tumour volume was calculated on
the basis of three dimensions of the lesion using the for-
mula for ellipsoid volume:
 4  a x b x c V = x 3.14 x
3 2
where a, b and c are the lengths of ellipsoid axes.
Before measurements the specimens were set in for-
maldehyde for 1-3 days.
In 10 patients the results of the measurements of
tumour volume in MR and on histological examination
after the operation were compared. Standard deviations
of mean value of volume differed statistically, due to
which the Student's T-test for non-parametric variance
distribution was used.
On the basis of MRI results the calculated volumes
and greatest dimensions in each group (10 patients opera-
ted on and 6 patients treated conservatively) were compa-
red with FIGO tumour stage, parametrial invasion and
the presence of metastases in lymph nodes.
Results
In the study group of 21 patients 3 cases demonstrated
in situ carcinoma foci on histological examination, in 1
case (patient operated on after radiotherapy) histologi-
cal examination found no cancer cells. In these cases
MR examination was negative. In 1 case of stage Ia MRI
result was also negative, while on histological examination
a flat infiltration (10 mm long and 0.4 mm deep) was reve-
aled. Preinvasive carcinoma (stage 0) and invasive in sta-
ge Ia are recognized exclusively in microscopic examina-
tion.
Comparative evaluation of tumour volume in MRI
and in histological examination based on Student's T-test
showed a high level of correlation of these two methods in
the 10 patients treated surgically. In MRI the mean value
of the volume was 51.303cm3 ± 44.65, in histological exa-
mination 54.41cm3 ± 39.14, p=0.764.
Analysis of the results of tumour stage, volume, gre-
atest dimension of the lesion, parametrial infiltration and
involvement of lymph nodes is presented in Tables I and
II. In surgically treated cases the tumour stage establi-
shed on the basis of the results of histological examina-
tions, in the conservatively treated group this grade was
established on the basis of clinical examination and ima-
ging results tranvaginal ultrasonography, CT.
Discussion
MRI is the method of choice in tumour volume asses-
sment. According to literature a comparative analysis of
the results of tumour volume measurements in MRI and
in transvaginal ultrasonographic examinations have shown
MRI to be a better measurement method [2]. According
to the authors of comparative analyses of tumour volume
measured in MRI or in postoperative specimens the re-
sults of both methods correlate well (p=0.983) [2-4]. We
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confirmed this, obtaining high correlation of the measure-
ments (p=0.764).
In the light of own results it was found that in all 10
cases with tumour size exceeding 50 cm3 the tumour sta-
ge was always higher than Ib. In all 6 cases with stage Ib
tumour volume was below 46 cm3.
In 1995 amendments were introduced to the FIGO
classification of tumour stage. The range between tumo-
ur dimensions in grade Ib was too high, therefore it was
divided into grades Ib and Ib2, with 40 mm of tumour
size as the cut-off point [2]. This arose directly from the
studies on the prognostic values of various parameters
of tumour evaluation, including volume. As stated by the
authors of these analyses, tumour volume correlated po-
orly with Ib clinical stage, in which tumours of big volume
were found [4]. In own material similar relationships we-
re found, with the range of tumour volume in Ib stage
varying from 0.02 cm3 to 45.7 cm3.
Comparing the results of greatest tumour dimen-
sion measurements in patients with Ib tumour stage in
the present material it was found that in one case this
dimension was 12 mm, while in the other cases the gre-
atest dimension did not exceed 70 mm.
In the group of patients with stage IIa and IIb the tu-
mour volumes ranged from 50.3 cm3 to 96 cm3, in one
case the volume was 156.6 cm3, while tumour dimensions
were in the range of 48 mm to 79 mm, in one case 95
mm. In 2 patients with tumour stage IVa the tumour volu-
me was 158.9 cm3 and 221.7 cm3, while the greatest di-
mension was 73 mm and 89 mm, respectively.
On the basis of the obtained results it may be said
that in cervical carcinoma patients the assessment of tu-
mour volume correlates better with FIGO stages I and II,
than with the greatest tumour dimension. The sensitivity
and specificity of MRI with tumour volume were 100% in
the differentiation of stage Ib from higher stages. Similar
observations were reported by Ishikawa [5]. In the re-
ports of other authors no statistically significant differen-
ces were found between tumour volume and tumour di-
mension (p=0.01) in tumour stage assessment [6].
In our material a correlation was found between tu-
mour volume and parametrial infiltration. In the group of
9 patients with parametrial involvement tumour volume
ranged between 50.3 cm3 and 156.6 cm3, only in 1 out of
9 patients (with volume 58.4 cm3) parametrial infiltra-
tion wasn't found. In 6 of 7 cases without parametrial in-
volvement tumour volume ranged between 0.02 cm3 and
45.7 cm3 and in 1 patient tumour volume was 58.4 cm3.
Tumour dimensions in the group with parametrial involve-
ment ranged between 55 and 95 mm, in those without
involvement they were within a range of 48 to 55 mm.
According to reports of studies on numerous cases tu-
mour volume was found to correlate with parametrial in-
volvement, but not with involvement of lymph nodes [6].
In own material we found no correlation between tumour
volume and lymph node metastases.
According to literature tumour volume is of progno-
stic importance in the prediction of treatment effects [3, 7-
-9]. The initial tumour volume before treatment shows
a better correlation with the therapeutic response than cli-
nical examination, stage in FIGO classification or the
grade of histological malignancy [10]. The 5-year survival
rate is between 91% in cases of tumour volume below
2.5 cm3 and 70% in those with 10-50 cm3 volume. The
survival rate of cases with tumour volume over 50 cm3 is
48% after 5 years [10]. Determination of tumour volume
is of prognostic significance in foreseeing survival witho-
ut disease progression [6].
Table I. Tumour stage according to FIGO, volume, greatest dimension of the tumour, parametrium infiltration and involvement 
of lymph nodes in 10 surgically treated patients
No. Tumour stage Volume (cm3) Greatest dimension (mm) Parametrium infiltration Lymph nodes involvement
1 IB 0.02 12 no no
2 IB 3.70 22 no no
3 IB 6.80 42 no no
4 IB 32.70 34 no no
5 IB 45.70 70 no no
6 IIA 53.10 48 yes yes
7 IIA 58.40 70 no yes
8 IIA 70.30 55 yes no
9 IIB 85.70 61 yes no
10 IIB 156.60 95 yes yes
Table II. FIGO tumour stage, volume, greatest dimension, parametrium infiltration, lymph nodes enlargement in 6 patients treated conservatively
No. Tumour stage Volume (cm3) Greatest dimension (mm) Parametrium infiltration Lymph nodes involvement
1 IB 31.5 44 no no
2 IIB 50.3 55 yes no
3 IIB 58.4 58 yes no
4 IIB 96.0 79 yes no
5 IVA 158.9 73 yes no
6 IVA 221.7 89 yes no
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In view of a short observation time these prelimina-
ry results cannot be interpreted as related to the 5-year
survival rate nor to therapeutic response. However the
study will be continued.
Conclusions
1. Correlation was found between MRI and post-surgical
histological examination regarding tumour volume me-
asurements, p=0.764.
2. In cervical carcinoma patients the sensitivity and speci-
ficity of MRI for tumour volume determination were
100% in the differentiation of cases with stage Ib from
other ones.
3. In cervical carcinoma patients the assessment of tu-
mour volume correlates better with stages I and II acc.
to FIGO classification than to the measurement of
the greatest dimension of the tumour.
4. Correlation between tumour volume and parametrial
invasion was found.
5. No correlation was found between tumour volume and
metastases to lymph nodes.
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